Brief: RIBOMIC in discussion to continue joint research with Otsuka Pharmaceutical on RBM001

Ribomic

11/01/2017 06:25

Jan 11 (Reuters) - RIBOMIC Inc  4591.T  : 
     
    * Says co is in discussion to continue joint research with 
Otsuka Pharmaceutical Co Ltd on RBM001 (midkine aptamers 
targeted) 
    * The former cooperation agreement have expired since Dec. 
2016 
 
    Source text in Japanese: https://goo.gl/FtLNsY 
    Further company coverage: 4591.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))